Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.

Clinical hemorheology and microcirculation - 1 Jan 2008

Vayá Amparo, Santaolaria Marisa, Micó Luisa, Calvo Javier, Oropesa Roberto, Villa Piedad, Todoli Jose, Simó María, Corella Dolores, Ricart Jose M

Abstract excerpt

Systemic lupus erythematosus (SLE) is characterised by increased venous and arterial thrombotic risk. Although antiphospholipid antibodies (APAs) have been shown to be related with thrombotic tendency in these patients, in more than 40% of them, thrombosis occurs without the presence of such anti...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anticardiolipin
Share to Blood Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lupus Coagulation Inhibitor

Share to Lupus Erythematosus, Systemic

Share to Mutation

Share to Risk Factors

Share to Thrombosis

Source

Identifiers

PMID: 19029633

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19029633-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.PMID 19029633Read ↗

Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.Semantic proximity Read ↗

Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.Semantic proximity Read ↗

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus.Semantic proximity Read ↗

Hypercoagulability in various autoimmune diseases: no association with factor V Leiden mutation.Semantic proximity Read ↗

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.Semantic proximity Read ↗

HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.Semantic proximity Read ↗

Factor V Leiden and prothrombin G20210A mutations and the risk of atherothrombotic events in systemic lupus erythematosus.Semantic proximity Read ↗

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLESemantic proximity Read ↗

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?Semantic proximity Read ↗

Genetic risk factors for thrombosis in systemic lupus erythematosus.Semantic proximity Read ↗

Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.Semantic proximity Read ↗

The Leiden mutation of coagulation factor V in Hungarian SLE patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.